Enveric Biosciences (NASDAQ: ENVB) is an innovative biotechnology company developing a next-generation mental health and oncology treatment clinical discovery platform, leveraging psychedelic-derived molecules for the mind and synthetic cannabinoids for the body. Enveric Biosciences' robust pipeline supports drug development from the clinic to commercialization for millions of patients in need around the world suffering from conditions that include cancer-related distress, PTSD and more.
The Science of CBD
Enveric Biosciences seeks to advance novel combinations of CBD with chemotherapeutic agents and immunotherapies.
Enveric Biosciences has a robust pipeline with multiple data points expected in 2021 for radiodermatitis and glioblastoma.